Article Text

other Versions

PDF

Progranulin mutations and ALS or ALS-FTD phenotypes
  1. JC Schymick (schymickj{at}mail.nih.gov)
  1. NIA, United States
  1. Y Yang (yyang22{at}jhmi.edu)
  1. Johns Hopkins University, United States
  1. PM Andersen (peter.andersen{at}neuro.umu.se)
  1. Umea University Hospital, Sweden
  1. JP Vonsattel (jgv2001{at}columbia.edu)
  1. Columbia University, United States
  1. M Greenway (greenwaymatt{at}yahoo.co.uk)
  1. Beaumont Hospital and RCSI, Republic of Ireland
  1. P Momeni (momeni{at}mail.nih.gov)
  1. NIA, United States
  1. J Elder (elderj{at}mail.nih.gov)
  1. NIA, United States
  1. A Chio (achio{at}usa.net)
  1. University of Turin, Italy
  1. G Restagno (grestagno{at}hotmail.com)
  1. A.S.O. O.I.R.M.-S.Anna, Turin, Italy
  1. W Robberecht (wim.robberecht{at}uz.kuleuven.ac.be)
  1. University of Leuven, Belgium
  1. C Dahlberg (catherine.dahlberg{at}neuro.umu.se)
  1. University of Umea, Sweden
  1. O Mukherjee (odity{at}icarus.wustl.edu)
  1. Washington University School of Medicine, United States
  1. A Goate (goate{at}icarus.wustl.edu)
  1. Washington University School of Medicine, United States
  1. N Graff-Radford
  1. Mayo Clinic College of Medicine, United States
  1. RJ Caselli
  1. Mayo Clinic Scottsdale, United States
  1. M Hutton (hutton.mike{at}mayo.edu)
  1. Mayo Clinic College of Medicine, United States
  1. J Gass (jennifer.gass{at}mayo.edu)
  1. Mayo Clinic College of Medicine, United States
  1. A Cannon (ashley.cannon{at}mayo.edu)
  1. Mayo Clinic College of Medicine, United States
  1. R Rademakers (rademakers.rossa{at}mayo.edu)
  1. Mayo Clinic College of Medicine, United States
  1. AB Singleton (singleta{at}mail.nih.gov)
  1. NIA, United States
  1. O Hardiman (ohard{at}iol.ie)
  1. Beaumont Hospital and RCSI, Republic of Ireland
  1. J Rothstein (jrothstein{at}jhmi.edu)
  1. Johns Hopkins University, United States
  1. J Hardy (hardyj{at}mail.nih.gov)
  1. NIA, United States
  1. BJ Traynor (traynorb{at}mail.nih.gov)
  1. NIA, United States

Abstract

Objective: Mutations in the progranulin (PGRN) gene were recently described as the cause of ubiquitin positive FTD. Clinical and pathological overlap between ALS and FTD prompted us to screen PGRN in patients with ALS and ALS-FTD.

Methods: The PGRN gene was sequenced in 272 cases of sporadic ALS, 40 familial ALS and 49 patients with ALS-FTD.

Results: Missense changes were identified in an ALS-FTD patient (p.S120Y) and in a single case of limb-onset sporadic ALS (p.T182M), though the pathogenicity of these variants remains unclear.

Conclusion: PGRN mutations are not a common cause of ALS phenotypes.

  • amyotrophic lateral sclerosis
  • amyotrophic lateral sclerosis - frontotemporal dementia
  • progranulin

Statistics from Altmetric.com

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.